Skip to content

Efficacy of AI camera for cervical cancer screening and for triage of abnormal testing A multicenter study by the Thai Gynecologic Cancer Society

Efficacy of AI camera for cervical cancer screening and for triage of abnormal testing A multicenter study by the Thai Gynecologic Cancer Society

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251229003
Enrollment
2000
Registered
2025-12-29
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer Cervical cancer, colposcopy, Dr CerviCARE, Artificial Intelligence

Interventions

Screening

Sponsors

Thai Gynecologic Cancer Society
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Group 1 Women aged 25 to 55 years undergoing cervical cancer screening Group 2 Women aged 25 to 55 years with abnormal cervical cancer screening results 2. Not menopausal 3. Able to understand and communicate in Thai 4. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Women with a prior history of abnormal cervical cancer screening results or a previous diagnosis of cervical cancer or other gynecologic cancers (both Group 1 and Group 2) 2. Women who have undergone hysterectomy including removal of the cervix (both Group 1 and Group 2) 3. Pregnant women (both Group 1 and Group 2) 4. Women with heavy bleeding from the cervix or uterus, or who are menstruating at the time of examination (both Group 1 and Group 2) 5. Women with suspected infection of the lower genital tract or cervix (both Group 1 and Group 2) 6. Women with abnormal vaginal discharge (Group 1 only) 7. Women with abnormal glandular-type screening results (Group 2 only)

Design outcomes

Primary

MeasureTime frame
Results of abnormal cervical lesion detection Immediately after test screening test,Results of abnormal cervical lesion detection Immediately after test Dr.CerviCARE AI

Secondary

MeasureTime frame
Diagnostic results from camera-acquired images 2 weeks after test Colonoscopy,Diagnostic results from camera-acquired images 2 weeks after test Dr.CerviCARE AI

Countries

Thailand

Contacts

Public ContactSiriwan Tangjitgamol

MedPark

siriwanonco@yahoo.com06492405471

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026